Nuclear survivin as a biomarker for non-small-cell lung cancer

被引：0
|
作者：
B Lu
A Gonzalez
P P Massion
Y Shyr
B Shaktour
D P Carbone
D E Hallahan
机构：
[1] Vanderbilt Ingram,Department of Radiation Oncology
[2] Cancer Center,Department of Pathology
[3] Vanderbilt University School of Medicine,Department of Medicine
[4] Vanderbilt Ingram,Department of Preventive Medicine
[5] Cancer Center,undefined
[6] Vanderbilt University School of Medicine,undefined
[7] Vanderbilt Ingram,undefined
[8] Cancer Center,undefined
[9] Vanderbilt University School of Medicine,undefined
[10] Vanderbilt Ingram,undefined
[11] Cancer Center,undefined
[12] Vanderbilt University School of Medicine,undefined
来源：
British Journal of Cancer | 2004年 / 91卷
关键词：
survivin; lung cancer; nucleus; tissue array; mitosis; apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Survivin inhibits apoptosis and promotes mitosis. We determined whether nuclear or cytoplasmic localisation of survivin predicts survival of 48 patients with resected non-small-cell lung cancer (NSCLC). Patients with nuclear staining of survivin had significantly worse survival (relative risk: 3.9, P=0.02). Therefore, survivin may be a biomarker for NSCLC.
引用
收藏
页码：537 / 540
页数：3
相关论文
共 50 条
  • [41] Follow-up in non-small-cell lung cancer
    Rothschild S.I.
    Lardinois D.
    Bremerich J.
    Tamm M.
    Bubendorf L.
    Papachristofilou A.
    Stoll H.
    Zippelius A.
    memo - Magazine of European Medical Oncology, 2014, 7 (2) : 97 - 101
  • [42] Clusterin modulates transdifferentiation of non-small-cell lung cancer
    Jin, Runsen
    Chen, Xingshi
    Han, Dingpei
    Luo, Xiaoying
    Li, Hecheng
    BMC CANCER, 2017, 17
  • [43] Different glomerulopathies accompanying non-small-cell lung cancer
    Paydas, S
    Soydas, B
    Paydas, S
    Balal, M
    Erdogan, S
    Tuncer, I
    MOUNT SINAI JOURNAL OF MEDICINE, 2005, 72 (04): : 279 - 281
  • [44] Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer
    Liu, Guangbo
    Pei, Fen
    Yang, Fengqing
    Li, Lingxiao
    Amin, Amit Dipak
    Liu, Songnian
    Buchan, J. Ross
    Cho, William C.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (02)
  • [45] Gene expression profiling of non-small-cell lung cancer
    Lacroix, Ludovic
    Commo, Frederic
    Soria, Jean-Charles
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2008, 8 (02) : 167 - 178
  • [46] Immunotherapy for non-small-cell lung cancer: current approaches
    Elisabeth Quoix
    Jean Marc Limacher
    Current Respiratory Care Reports, 2014, 3 (1): : 19 - 25
  • [47] Immunotherapy for non-small-cell lung cancer: current approaches
    Quoix, Elisabeth
    Limacher, Jean Marc
    CURRENT PULMONOLOGY REPORTS, 2014, 3 (01) : 19 - 25
  • [48] Surgery for oligometastatic disease in non-small-cell lung cancer
    Van Schil, Paul E.
    Hendriks, Jeroen M.
    Carp, Laurens
    Lauwers, Patrick R.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (12) : 1931 - 1938
  • [49] Lymph nodal staging for non-small-cell lung cancer
    Jiwnani, Sabita
    Karimundackal, George
    Mehta, Marzi
    Pramesh, C. S.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2012, 42 (05) : 907 - 907
  • [50] Neoadjuvant immunotherapy in resectable non-small-cell lung cancer
    Chen, Lanyi Nora
    Wei, Alexander Z.
    Shu, Catherine A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
12345